암 치료용 신규 약물전달 시스템 시장 규모, 점유율, 동향 및 성장 분석 보고서(2026-2034년)

The global novel drug delivery systems in cancer therapy market report size is expected to reach USD 40.11 Billion in 2034 from USD 20.64 Billion in 2025, growing at a CAGR of 7.66% during 2026-2034.The Novel Drug Delivery Systems in Cancer Therapy Market is experiencing robust growth as the demand for effective and targeted cancer treatments continues to rise. These advanced drug delivery systems are designed to improve the bioavailability and therapeutic efficacy of anticancer agents while minimizing side effects. The increasing prevalence of cancer and the growing focus on personalized medicine are driving the development of innovative drug delivery technologies, such as nanoparticles, liposomes, and micelles. As researchers and pharmaceutical companies prioritize the advancement of cancer therapies, the market for novel drug delivery systems is expected to flourish.

Technological advancements are playing a crucial role in shaping the future of the novel drug delivery systems in cancer therapy market. Innovations in formulation technologies and targeting strategies are enhancing the precision of drug delivery, allowing for localized treatment of tumors while sparing healthy tissues. Additionally, the integration of smart technologies, such as stimuli-responsive systems and real-time monitoring, is improving the effectiveness and safety of cancer therapies. As manufacturers continue to invest in research and development, the market is likely to see increased adoption of novel drug delivery systems across various cancer treatment modalities.

Moreover, the growing emphasis on collaboration between academia and industry is influencing the novel drug delivery systems in cancer therapy market. As researchers and pharmaceutical companies work together to develop and validate new delivery technologies, the pace of innovation is expected to accelerate. This trend is driving the establishment of partnerships and collaborations that facilitate the translation of research findings into clinical applications. As the market continues to evolve, the integration of technology, collaboration, and patient-centric approaches will be key drivers of success.

Our reports are carefully developed to deliver comprehensive and actionable insights across a wide range of industries and markets. Each report includes several essential components designed to provide a complete understanding of the market environment:

Market Overview: This section provides a clear introduction to the market, including key definitions, classifications, and an overview of the current industry landscape.

Market Dynamics: A detailed evaluation of the primary drivers, restraints, opportunities, and challenges shaping market growth. It covers factors such as technological developments, regulatory frameworks, and evolving industry trends.

Segmentation Analysis: A structured breakdown of the market into key segments based on product type, application, end-user, and geographic region. This section highlights the performance, growth potential, and contribution of each segment.

Competitive Landscape: An in-depth assessment of leading market participants, including their market positioning, product portfolios, strategic initiatives, and financial performance. It provides valuable insights into competitive dynamics and the strategies adopted by key players.

Market Forecast: Data-driven projections of market size and growth patterns over a defined forecast period. This section incorporates historical trends, current market conditions, and quantitative analysis to illustrate expected future developments.

Regional Analysis: A comprehensive review of market performance across major geographic regions, identifying high-growth areas and regional trends to better understand localized market opportunities.

Emerging Trends and Opportunities: Identification of significant market trends, technological advancements, and new investment opportunities. This section highlights potential growth areas and future industry developments.

Customization Options: We offer flexible customization services to tailor reports according to specific client requirements. This may include additional segmentation, country-level analysis, competitor profiling, customized data points, or focused insights on particular market segments to better support strategic decision-making.

MARKET SEGMENTATION

By Product

• Nanoparticles (Liposomes, Polymer, Micelles, Other nanoparticles)
• Embolization particles (PVA particles, Drug-eluting beads, Liquid emboli, Other Embolization particles)

COMPANIES PROFILED

• Teva Pharmaceutical Industries Ltd., Johnson & Johnson Services Inc., Galen, Merrimack Pharmaceuticals Inc., Shire, Samyang Biopharmaceuticals Corporation, Celgene Corporation, Spectrum Pharmaceuticals Inc., Other market players.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL NOVEL DRUG DELIVERY SYSTEMS IN CANCER THERAPY MARKET: BY PRODUCT 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Product
• 4.2. Nanoparticles (Liposomes, Polymer, Micelles, Other nanoparticles) Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Embolization particles (PVA particles, Drug-eluting beads, Liquid emboli, Other Embolization particles) Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL NOVEL DRUG DELIVERY SYSTEMS IN CANCER THERAPY MARKET: BY REGION 2022-2034 (USD MN)

• 5.1. Regional Outlook
• 5.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 5.2.1 By Product
  • 5.2.2 United States
  • 5.2.3 Canada
  • 5.2.4 Mexico
• 5.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 5.3.1 By Product
  • 5.3.2 United Kingdom
  • 5.3.3 France
  • 5.3.4 Germany
  • 5.3.5 Italy
  • 5.3.6 Russia
  • 5.3.7 Rest Of Europe
• 5.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 5.4.1 By Product
  • 5.4.2 India
  • 5.4.3 Japan
  • 5.4.4 South Korea
  • 5.4.5 Australia
  • 5.4.6 South East Asia
  • 5.4.7 Rest Of Asia Pacific
• 5.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 5.5.1 By Product
  • 5.5.2 Brazil
  • 5.5.3 Argentina
  • 5.5.4 Peru
  • 5.5.5 Chile
  • 5.5.6 Rest of Latin America
• 5.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 5.6.1 By Product
  • 5.6.2 Saudi Arabia
  • 5.6.3 UAE
  • 5.6.4 Israel
  • 5.6.5 South Africa
  • 5.6.6 Rest of the Middle East And Africa

Chapter 6. COMPETITIVE LANDSCAPE

• 6.1. Recent Developments
• 6.2. Company Categorization
• 6.3. Supply Chain & Channel Partners (based on availability)
• 6.4. Market Share & Positioning Analysis (based on availability)
• 6.5. Vendor Landscape (based on availability)
• 6.6. Strategy Mapping

Chapter 7. COMPANY PROFILES OF GLOBAL NOVEL DRUG DELIVERY SYSTEMS IN CANCER THERAPY INDUSTRY

• 7.1. Top Companies Market Share Analysis
• 7.2. Company Profiles
  • 7.2.1 Teva Pharmaceutical Industries Ltd
  • 7.2.2 Johnson & Johnson Services Inc
  • 7.2.3 Galen
  • 7.2.4 Merrimack Pharmaceuticals Inc
  • 7.2.5 Shire
  • 7.2.6 Samyang Biopharmaceuticals Corporation
  • 7.2.7 Celgene Corporation
  • 7.2.8 Spectrum Pharmaceuticals Inc
  • 7.2.9 Other Market Players